The STING pathway targeting technologies market, featuring a healthy pipeline of therapeutics
STING, having generated significant interest within the medicalresearch community, is currently considered one of the fastest growing areas ofcancer immunotherapy and is being pursued by several large pharmaceuticalcompanies
Roots Analysis is pleased to announce the publication of its recentstudy, titled, “STINGPathway Targeting Therapeutics and Technologies,2020-2030.”
The reportfeatures an extensive study of the current market landscape and futurepotential of these therapeutics and affiliated technologies, over the nextdecade. This study focuses specifically on small molecule STING modulators. Thereport features an in-depth analysis, highlighting the diverse capabilities ofstakeholders engaged in this domain. In addition to other elements, the studyincludes:
§ A detailed assessment of the current market landscape oftherapeutics targeting STING Pathway.
§ A detailed assessment of the current market landscape ofvarious technology platforms that are being actively used for the developmentof STING modulators.
§ Detailed profiles of developers of therapeutics targetingSTING pathway (shortlisted on the basis of phase of development ofpipeline products).
§ An in-depth analysis of more than 280 grants that have beenawarded to research institutes engaged in STING pathway targetingtherapeutics-related projects.
§ An analysis of the initiatives of big pharma playersengaged in this domain.
§ An analysis of the start-ups / small players (establishedin the last ten years, less than 50 employees) engaged in the developmentof STING pathway targeting therapeutics.
§ A detailed publication analysis of more than 300peer-reviewed, scientific articles that have been published during the period2019 - Q1 2020.
§ An analysis of the partnerships that have been establishedin this domain, in the recent past.
§ An analysis of the investments made in this domain.
§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)
§ Types of Payment
§ Upfront Payments
§ Milestone Payments
§ Type of STING Modulator
§ Agonist
§ Antagonist
§ Key Therapeutic Area(s)
§ Oncological Disorders
§ Inflammatory Disorders
§ Infectious Diseases
§ Others
§ Route of Administration
§ Intratumoral
§ Intravenous
§ Oral
§ Subcutaneous
§ Others
§ Type of Molecule
§ Non-nucleotide
§ Cyclic Dinucleotide
§ Live Biotherapeutics
§ Oncolytic Peptides
§ Synthetic Peptides
§ Others
§ Key Geographical Regions
§ North America
§ Europe
§ Asia-Pacific
Keycompanies covered in the report
§ Aduro Biotech
§ Bristol Myers Squibb
§ Eisai
§ GlaxoSmithKline
§ ImmuneSensorTherapeutics
§ Merck
§ Noxopharm
§ Spring BankPharmaceuticals
§ Synlogic
Formore information please click on the following link:
Other Recent Offerings
1. NuclearMedicine and Radiopharmaceuticals Manufacturing Market, 2020-2030
2. GlobalPsychedelic TherapeuticsMarket by Type of Psychedelic Substance (Ketamine, Psilocybin, MDMA andOthers), by Origin (Natural and Synthetic), by Type of Therapy (Monotherapy,Combination and Others), by Route of Administration (Oral, Intravenous,Intranasal and Others) and by Key Geographies (North America, Europe and Asia-Pacific and rest of the world): Industry Trends and Global Forecasts, 2020-2030
3. EndocannabinoidSystem Targeted TherapeuticsMarket, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
